TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35869628

Group type: EXPERIMENTAL
Intervention: 15-min brief advice and counseling
Number of subjects: 351

Group type: COMPARATOR
Intervention: Patient information leaflet (PIL)
Number of subjects: 351

Group type: COMPARATOR
Intervention: 5-min brief advice
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: All groups (15-min, 5-min, PIL)
Number of subjects: 351
Study: 36170556

Group type: EXPERIMENTAL
Intervention: Peer-led single-session intervention targeting sociocultural pressures of body image
Number of subjects: 471

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 471
Study: 34588232

Group type: EXPERIMENTAL
Intervention: Healing Right Way (HRW) rehabilitation programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Culturally secure services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultural security training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aboriginal Brain Injury Coordinator role
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 0
Study: 35916932

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the theory of planned behavior (TPB), consisting of six weekly sessions.
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the theory of planned behavior (TPB).
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 162
Study: 34261332

Group type: EXPERIMENTAL
Intervention: Digital health intervention (DHI) including a smartphone application, smartwatch, and blood pressure monitor for 30 days post-discharge.
Number of subjects: 1064

Group type: COMPARATOR
Intervention: Control group (historical control).
Number of subjects: 1064

Group type: EXPERIMENTAL
Intervention: Digital health intervention (DHI).
Number of subjects: 1064
Study: 32372570

Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 207

Group type: COMPARATOR
Intervention: Home safety control group
Number of subjects: 207
Study: 33976287

Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy (two 200 ml transfusions over 24 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy
Number of subjects: 40
Study: 33377451

Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone (oral or intravenous) in adults with COVID-19 requiring oxygen or mechanical ventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternate equivalent doses of steroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Convalescent plasma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interleukin-6 inhibitors (e.g., tocilizumab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empiric antimicrobial treatment for likely coinfecting pathogens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Close monitoring without additional empiric antimicrobials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxychloroquine ± azithromycin or lopinavir‐ritonavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Remdesivir
Number of subjects: 0
Study: 32719969

Group type: COMPARATOR
Intervention: Intermittent theta burst stimulation (iTBS), 10 sessions, delivered at 80% of motor threshold, 1,800 pulses, to the right dorsolateral prefrontal cortex.
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham treatment (control group)
Number of subjects: 47
Study: 616508446

Group type: EXPERIMENTAL
Intervention: Right visual field presentation during recognition test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Left visual field presentation during recognition test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acquisition with dominant limb (both left and right-handers)
Number of subjects: 0
Study: 33165633

Group type: EXPERIMENTAL
Intervention: LAF (Laminar Air Flow)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-LAF
Number of subjects: 12
Study: 32086163

Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 0
Study: 34715158

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) program
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Emotion Regulation (ER) program
Number of subjects: 316

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 316
Study: 34587384

Group type: EXPERIMENTAL
Intervention: Maintenance group (continued antidepressant therapy)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Discontinuation group (taper and discontinue therapy with placebo)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Discontinuation group
Number of subjects: 478
Study: 34942577

Group type: EXPERIMENTAL
Intervention: PS + UCT
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: UCT-only
Number of subjects: 594

Group type: COMPARATOR
Intervention: Comparison
Number of subjects: 594
Study: 34301669

Group type: EXPERIMENTAL
Intervention: High-load resistance training (HL-RT) combined with aerobic training (AT) at 70%-80% of one repetition maximum (1-RM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-load resistance training (LL-RT) combined with aerobic training (AT) at 30%-40% of one repetition maximum (1-RM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aerobic training (AT) alone as standard care
Number of subjects: 60
Study: 33267539

Group type: EXPERIMENTAL
Intervention: Intramuscular injections of muramylpeptide composition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral hygiene instructions, professional oral hygiene procedures, and root scaling
Number of subjects: 40
Study: 34711479

Group type: EXPERIMENTAL
Intervention: 15 g L-Citrulline
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 32645159

Group type: EXPERIMENTAL
Intervention: Advanced reproductive age associated with waist circumference (>88 vs ≤88 cm)
Number of subjects: 1449

Group type: EXPERIMENTAL
Intervention: Advanced reproductive age associated with hemoglobin (≥12 vs <12 g/dL)
Number of subjects: 1449

Group type: EXPERIMENTAL
Intervention: Advanced reproductive age associated with region of residence (sub-Saharan Africa)
Number of subjects: 1449

Group type: EXPERIMENTAL
Intervention: Advanced reproductive age associated with region of residence (Latin America and the Caribbean)
Number of subjects: 1449

Group type: EXPERIMENTAL
Intervention: Median age at final menstrual period among postmenopausal WWH
Number of subjects: 1449
Study: 35738114

Group type: EXPERIMENTAL
Intervention: Tai Chi app and Facebook health tips
Number of subjects: 35

Group type: COMPARATOR
Intervention: Facebook health tips only
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 32549135

Group type: EXPERIMENTAL
Intervention: Solid lipid Boswellia serrata particles (SLBSP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardized Boswellia serrata gum extract (BSE)
Number of subjects: 0
Study: 35235993

Group type: EXPERIMENTAL
Intervention: Telehealth education via WeChat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35644936

Group type: EXPERIMENTAL
Intervention: Wearing a face mask during cardiopulmonary exercise tests (CPET)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Wearing a face mask during CPET
Number of subjects: 34
Study: 32737210

Group type: EXPERIMENTAL
Intervention: Tailored, face-to-face feedback and help-seeking advice on mental health screening
Number of subjects: 155
Study: 34911336

Group type: EXPERIMENTAL
Intervention: Amivantamab + Lazertinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Osimertinib
Number of subjects: 0
Study: 35278844

Group type: EXPERIMENTAL
Intervention: Bilateral Gow-gates block
Number of subjects: 0

Group type: COMPARATOR
Intervention: IV Morphine
Number of subjects: 0
Study: 35101958

Group type: EXPERIMENTAL
Intervention: Intra-arterial treatment (IAT)
Number of subjects: 649

Group type: COMPARATOR
Intervention: Intravenous thrombolysis (IVT) preceding IAT
Number of subjects: 649
Study: 33991310

Group type: EXPERIMENTAL
Intervention: Nitazoxanide 500 mg BD per oral for 10 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metronidazole 2-2.5 g/day IV for inpatients or 2-2.4 g/day oral for outpatients for 14 days
Number of subjects: 60
Study: 35476706

Group type: EXPERIMENTAL
Intervention: Extended antibiotic course (13-14 days duration)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Standard antibiotic course (5-6 days duration)
Number of subjects: 324
Study: 34229149

Group type: EXPERIMENTAL
Intervention: amoxicillin
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: ibuprofen
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: prednisolone
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: amoxicillin plus prednisolone
Number of subjects: 170

Group type: COMPARATOR
Intervention: metamizole/acetaminophen
Number of subjects: 170
Study: 33730519

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 36123994

Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting IVDD risk
Number of subjects: 309

Group type: COMPARATOR
Intervention: Angiotensin II (AngII) level in peripheral blood
Number of subjects: 309
Study: 33667741

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) at 40 mm Hg for 45 minutes directly after surgery
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (no IPC)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 186
Study: 34363104

Group type: EXPERIMENTAL
Intervention: Modified Extended Coronally Advanced Flap (MECAF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Supra‐periosteal flap (TUN)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pain evaluation using Visual Analog Scale (VAS)
Number of subjects: 20
Study: 32868152

Group type: EXPERIMENTAL
Intervention: Angiotensin II plus standard‐of‐care vasopressors (n=9)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo plus standard‐of‐care vasopressors (n=7)
Number of subjects: 16
Study: 33350170

Group type: EXPERIMENTAL
Intervention: Mycophenolate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclophosphamide (placebo treatment period)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Independent cohort
Number of subjects: 0
Study: 35502452

Group type: EXPERIMENTAL
Intervention: Coaching program (physical activity, home visits, weekly phone calls)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 84
Study: 33844262

Group type: EXPERIMENTAL
Intervention: TENS stimulation
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Water immersion
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 115
Study: 34182603

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen up to 60 l.min-1 at 100% FIO2
Number of subjects: 132

Group type: COMPARATOR
Intervention: Low-flow nasal oxygen at 4 l.min-1 plus oxygen through an oxygenating mouthguard totalling 8 l.min-1
Number of subjects: 132
Study: 33321089

Group type: EXPERIMENTAL
Intervention: PREHAB (4 weeks before surgery)
Number of subjects: 95

Group type: COMPARATOR
Intervention: REHAB (8 weeks after surgery)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups (PREHAB and REHAB)
Number of subjects: 95
Study: 34476774

Group type: EXPERIMENTAL
Intervention: Continuous nursing care (CNC)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional nursing care
Number of subjects: 134
Study: 32654677

Group type: EXPERIMENTAL
Intervention: Nutrition/stimulation/hygiene education intervention
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 155
Study: 33858441

Group type: EXPERIMENTAL
Intervention: Low sulfur amino acid (SAA) diet (total diet SAA 15–25 mg/kg body weight/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: High sulfur amino acid (SAA) diet (total diet SAA 50–60 mg/kg body weight/day)
Number of subjects: 60
Study: 32476640

Group type: EXPERIMENTAL
Intervention: Rango Cards game intervention
Number of subjects: 319

Group type: COMPARATOR
Intervention: Control group (no game or material provided)
Number of subjects: 319
Study: 33439140

Group type: EXPERIMENTAL
Intervention: Sanadak app (cognitive behavioral therapy-based self-help)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control group (psychoeducational reading material)
Number of subjects: 133
Study: 33022957

Group type: EXPERIMENTAL
Intervention: Monitoring salt concentration in soups
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Low-sodium seasoning
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control: no monitoring
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control: regular seasoning
Number of subjects: 195
Study: 35267246

Group type: EXPERIMENTAL
Intervention: Luseogliflozin (2.5 mg, once daily)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Voglibose (0.2 mg, three times daily)
Number of subjects: 83
Study: 33131028

Group type: EXPERIMENTAL
Intervention: CRISPR/dCas9‐SunTag labeling system with redesigned signal module (two copies of EGFP, NLS removed)
Number of subjects: 0
Study: 32142518

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Environment (IVE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Information Sheet (Control)
Number of subjects: 0
Study: 34014324

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) intervention, including psychosocial support and health coaching, maintained contact for 30 days postdischarge.
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) intervention for participants discharged to rehabilitation.
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) intervention for participants discharged home.
Number of subjects: 550

Group type: COMPARATOR
Intervention: Usual care (control group) including routine care from primary care clinics and outpatient referrals.
Number of subjects: 550
Study: 36277941

Group type: EXPERIMENTAL
Intervention: Weekly voice message intervention transmitted through mobile phone from recruitment in the first trimester until two weeks postpartum.
Number of subjects: 458

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 458
Study: 33247703

Group type: EXPERIMENTAL
Intervention: Text-message and infographic
Number of subjects: 396

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 396
Study: 34538690

Group type: EXPERIMENTAL
Intervention: CBT4CBT
Number of subjects: 63

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 63
Study: 34224476

Group type: EXPERIMENTAL
Intervention: SS-OCT
Number of subjects: 30

Group type: COMPARATOR
Intervention: RSC
Number of subjects: 30

Group type: COMPARATOR
Intervention: DSP
Number of subjects: 30
Study: 33300266

Group type: EXPERIMENTAL
Intervention: Proanthocyanidin (PA) for 1 min
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) for 3 min
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Proanthocyanidin (PA) for 1 min followed by CPP-ACP for 3 min
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups after 6 months
Number of subjects: 80
Study: 32588785

Group type: EXPERIMENTAL
Intervention: Change in physical activity (PA) during pregnancy
Number of subjects: 89
Study: 34474578

Group type: EXPERIMENTAL
Intervention: Combined deep cervical flexor motor-control training and lumbar motor control exercise
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Deep cervical flexor motor control training alone
Number of subjects: 113

Group type: COMPARATOR
Intervention: Passive treatment and education
Number of subjects: 113
Study: 33305818

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (600,000 IU)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 145
Study: 32452142

Group type: EXPERIMENTAL
Intervention: Female hormones users
Number of subjects: 3211
Study: 35172786

Group type: EXPERIMENTAL
Intervention: Beekeeping training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Entrepreneurship training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 0
Study: 33952558

Group type: EXPERIMENTAL
Intervention: LIVES for Families PFA training programme
Number of subjects: 80
Study: 33006952

Group type: EXPERIMENTAL
Intervention: Electrical vestibular nerve stimulation (VeNS) administered for 30 minutes, 1 hour prior to sleep onset for 14 days using ML1000 device (Neurovalens, UK)
Number of subjects: 0
Study: 34448694

Group type: EXPERIMENTAL
Intervention: Test preparation (250 mg) in fasting group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Reference preparation (250 mg) in fasting group
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Test preparation (250 mg) in postprandial group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Reference preparation (250 mg) in postprandial group
Number of subjects: 56
Study: 32871674

Group type: EXPERIMENTAL
Intervention: Short-term goal condition
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Long-term goal condition
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Fear proneness
Number of subjects: 127
Study: 32746952

Group type: EXPERIMENTAL
Intervention: 10 g daily of 99% cocoa chocolate for 6 months
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 132
Study: 35151410

Group type: EXPERIMENTAL
Intervention: Balovaptan (10 mg daily for 24 weeks)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo (daily for 24 weeks)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Balovaptan
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study: 33910836

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA) instillations before TURBT and cystoscopy
Number of subjects: 328

Group type: COMPARATOR
Intervention: Control group (without 5-ALA instillations)
Number of subjects: 328
Study: 32697556

Group type: EXPERIMENTAL
Intervention: 0.5% timolol maleate self-instilled using an alternative method
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.5% timolol maleate administered by a trained clinician
Number of subjects: 30
Study: 35953083

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention targets including BMI, exercise capacity (peak V̇O2), and health literacy (HL)
Number of subjects: 499
Study: 32950444

Group type: EXPERIMENTAL
Intervention: MitraClip intervention
Number of subjects: 0
Study: 36314321

Group type: EXPERIMENTAL
Intervention: Omega-3 + standard therapy (hydroxyurea and folic acid daily with ibuprofen as needed)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Vitamin D + standard therapy (hydroxyurea and folic acid daily with ibuprofen as needed)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 165
Study: 34400963

Group type: EXPERIMENTAL
Intervention: Semelil (test)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 44
Study: 34632922

Group type: EXPERIMENTAL
Intervention: Proton therapy (50 Gy in 25 fractions)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Proton therapy (40 Gy in 15 fractions)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Proton therapy with anatomical evaluation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Plan adaptation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Robust optimization
Number of subjects: 43
Study: 32456617

Group type: EXPERIMENTAL
Intervention: DL-3-n-butylphthalide (NBP) 200 mg three times daily for four weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo 20 mg three times daily for four weeks
Number of subjects: 120
Study: 35166585

Group type: EXPERIMENTAL
Intervention: 1-day training plus feedback
Number of subjects: 139

Group type: COMPARATOR
Intervention: No training or feedback
Number of subjects: 139
Study: 32811342

Group type: EXPERIMENTAL
Intervention: Radioiodine (RAI) treatment, fixed dose of 15 mCi
Number of subjects: 83

Group type: COMPARATOR
Intervention: Long-term Methimazole (MMI) treatment, starting dose of 10 mg daily, decreased to 4.9±1.0, 4.3±1.0, 4.4±1.4, 4.3±1.8, and 3.7±1.3 mg after 1, 2, 3, 4, and 5 years respectively
Number of subjects: 83
Study: 35924814

Group type: EXPERIMENTAL
Intervention: More-intensive BP management (target SBP ≤ 120 mmHg within 1 hour)
Number of subjects: 2257

Group type: COMPARATOR
Intervention: Less-intensive BP management (target SBP 140-180 mmHg)
Number of subjects: 2257
Study: 32051177

Group type: EXPERIMENTAL
Intervention: AI2 personal nudging system (text messages for missed medications or health checks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AI2 clinical decision support tool (alerts presented to community mental health professionals)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation protocols for AI2
Number of subjects: 0
Study: 36462115

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 0
Study: 33960149

Group type: EXPERIMENTAL
Intervention: 10 mg of empagliflozin for 12 weeks
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 86
Study: 36137900

Group type: EXPERIMENTAL
Intervention: Public health messages
Number of subjects: 2701

Group type: EXPERIMENTAL
Intervention: $10 financial incentive
Number of subjects: 2701

Group type: EXPERIMENTAL
Intervention: $50 financial incentive
Number of subjects: 2701

Group type: EXPERIMENTAL
Intervention: Simple vaccination appointment scheduler
Number of subjects: 2701

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2701
Study: 33508723

Group type: EXPERIMENTAL
Intervention: Uncemented parallel‐sided femoral component implantation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Postoperative walking activity (measured three months after surgery)
Number of subjects: 65